Himstead, A.S.; Chen, J.W.; Chu, E.; Perez-Rosendahl, M.A.; Zheng, M.; Mathew, S.; Yuen, C.A.
Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma. Biomedicines 2025, 13, 201.
https://doi.org/10.3390/biomedicines13010201
AMA Style
Himstead AS, Chen JW, Chu E, Perez-Rosendahl MA, Zheng M, Mathew S, Yuen CA.
Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma. Biomedicines. 2025; 13(1):201.
https://doi.org/10.3390/biomedicines13010201
Chicago/Turabian Style
Himstead, Alexander S., Jefferson W. Chen, Eleanor Chu, Mari A. Perez-Rosendahl, Michelle Zheng, Sherin Mathew, and Carlen A. Yuen.
2025. "Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma" Biomedicines 13, no. 1: 201.
https://doi.org/10.3390/biomedicines13010201
APA Style
Himstead, A. S., Chen, J. W., Chu, E., Perez-Rosendahl, M. A., Zheng, M., Mathew, S., & Yuen, C. A.
(2025). Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma. Biomedicines, 13(1), 201.
https://doi.org/10.3390/biomedicines13010201
